Newswise Feature Channel: Vaccines

Swine Viral Disease Conference Celebrates Industry Leaders, Students

College of Veterinary Medicine, University of Illinois Urbana-Champaign — Wed, 18 Dec 2024 18:55:10 EST

Swine Viral Disease Conference Celebrates Industry Leaders, Students

Fewer Kids are Getting Flu Shots, According to CDC

George Washington University — Mon, 16 Dec 2024 19:30:25 EST

Staphylococcus Aureus Thwarts Vaccines by Turning on a Protein That Halts Immune Response

University of California San Diego — Mon, 16 Dec 2024 12:00:00 EST

After dozens of clinical trials, there are still no effective vaccines against Staphylococcus aureus. In two new studies, scientists report that the pathogen turns on the protein interleukin 10, shutting down the protective vaccine response. But blocking the protein restores vaccine efficacy in an animal model.

Grant Will Fund Development of Vaccines to Prevent Dementia

Washington University in St. Louis — Thu, 12 Dec 2024 20:40:43 EST

WashU researchers are working to design vaccines that could potentially prevent the buildup of inflammatory protein accumulations in the brain, which is one of the precursors to developing Alzheimer's disease

Mpox Vaccination Rates Highest Among Cisgender Sexual Minority Men

Rutgers University-New Brunswick — Tue, 10 Dec 2024 15:15:46 EST

As a second wave of the viral disease looms, Rutgers Health researchers call for more studies on long-term immunity.

HPV Genotype-Specific Prevalence and Infection Risks: A 10-Year Population-Based Study From the United States

University of New Mexico Comprehensive Cancer Center — Tue, 10 Dec 2024 14:20:12 EST

Americans Are Uninformed About and Undervaccinated for HPV

Keck Medicine of USC — Tue, 10 Dec 2024 11:00:10 EST

Research shows that HPV accounts for 70% of all throat cancers, but only one-third of the public is aware that HPV causes throat cancer

Scientists Decode Antioxidants from Radiation-Proof Bacteria, Deinococcus radiodurans

Uniformed Services University of the Health Sciences (USU) — Mon, 09 Dec 2024 15:00:00 EST

A groundbreaking study has revealed the structure of a remarkable antioxidant found in Deinococcus radiodurans--dubbed "Conan the bacterium" for its ability to withstand extreme radiation. This discovery could have far-reaching applications, including the development of radiation-inactivated vaccines, protecting astronauts during deep-space missions, and preparing for radiation emergencies.

Children's Hospital of Philadelphia Researchers Find Rotavirus Vaccine is Safe for Use in NICU Babies

Children's Hospital of Philadelphia — Mon, 09 Dec 2024 00:05:00 EST

Researchers found that transmission of rotavirus vaccine strains in a neonatal intensive care unit (NICU) is rare and without clinical consequences, strongly suggesting that giving the rotavirus vaccine to eligible infants during their hospitalization provides immune benefits that outweigh any risks. The findings could serve as the basis for a change in clinical practice.

Tip Sheet: New Insights on RSV and Malaria, Metastatic Breast Cancer Resources for Patients -- and Fred Hutch at ASH

Fred Hutchinson Cancer Center — Thu, 05 Dec 2024 09:00:27 EST

Below are summaries of recent Fred Hutch Cancer Center research findings, patient stories and other news.

The Medical Minute: Shingles and Its Shot: What You Need to Know to Stay Healthy

Penn State Health — Thu, 05 Dec 2024 07:45:55 EST

The same virus that causes chickenpox can also reemerge as shingles, causing a painful string of rashes. A Penn State Health family medicine physician discusses the symptoms and why he recommends the shingles vaccine for adults 50 and older and adults with weakened immune systems.

Wistar Institute Researchers Design Novel Immunotherapy for Brain Cancer

Wistar Institute — Tue, 03 Dec 2024 11:55:34 EST

The Wistar Institute's David B. Weiner, Ph.D., and his laboratory created a new therapeutic design for glioblastoma, the deadliest form of brain cancer. The lab engineered molecules called trispecifics that connect cancer-killing T cells with not just one but two different brain cancer receptors.

New Study Reveals Timing Matters for COVID-19 Boosters

University of North Carolina at Charlotte — Mon, 02 Dec 2024 14:55:42 EST

Timing COVID-19 booster shots correctly could greatly enhance their effectiveness, according to a new study conducted by researchers from the University of North Carolina at Charlotte and the Yale School of Public Health.

New Method Discovered for Controlling Molecular Patterns on Liquid Droplets

Bar-Ilan University — Mon, 02 Dec 2024 13:55:02 EST

A team of researchers from Bar-Ilan University, in collaboration with researchers from Leiden University (The Netherlands) and Complutense University of Madrid (Spain), has uncovered a previously unknown phenomenon that could revolutionize the way we design materials at the molecular level. By unlocking a transformation between two types of structural defects on the surface of liquid droplets, the research opens new possibilities for controlling molecular patterns with unprecedented precision. This discovery has broad applications across a range of technologies, including vaccine design, the creation of self-assembling structures, and the synthesis of complex nanoparticles.

Expanding HPV Vaccination to All Adults Aged 27-45 Years Unlikely to Be Cost-Effective or Efficient for HPV-Related Cancer Prevention

American College of Physicians (ACP) — Mon, 25 Nov 2024 17:00:00 EST

A modeling study projected that HPV vaccination programs for adults aged 27 to 45 years could benefit subgroups at higher risk for HPV, but overall, the approach is more costly and less effective than vaccinating younger people.

WHO Authorizes First Monkeypox Vaccine for Children

George Washington University — Mon, 25 Nov 2024 09:10:59 EST

New Research Could Pave Way for Vaccine Against Deadly Wildlife Disease

Michigan State University — Tue, 19 Nov 2024 15:35:18 EST

Sean Crosson, a Professor Rudolph Hugh Endowed Chair in Michigan State University's Department of Microbiology, Genetics and Immunology, has been awarded a $2.4 million grant from the National Institutes of Health's National Institute of Allergy and Infectious Diseases to study the cause of that very disease, Brucella abortus.

CDC Lowers Age for Adult Pneumonia Vaccine From 65 to 50

University of California, Los Angeles (UCLA), Health Sciences — Mon, 18 Nov 2024 12:50:10 EST

Como Mantener a los Mayores Fuera del Hospital Durante la Temporada de la Gripe

Cedars-Sinai — Mon, 18 Nov 2024 11:10:11 EST

La influenza puede ser una enfermedad desagradable de una semana de duracion y un inconveniente para muchas personas, pero puede tener consecuencias graves para los adultos mayores.

Argonne to Explore Novel Ways to Fight Cancer and Transform Vaccine Discovery with Over $21 Million From ARPA-H

Argonne National Laboratory — Thu, 14 Nov 2024 14:35:19 EST

Argonne has received up to $21 million from ARPA-H to use AI and supercomputing in two projects: one targeting hard-to-treat tumors, and another aiming to create vaccines for multiple viral threats, including cancer and pandemics.